Updated:
Medical Angels
Medical Angels, the clinician-led syndicate co-founded by Hansra and Bi, raised a $40M venture fund in 2026 to back early-stage digital health across...
Medical Angels
Dr Amandeep Hansra and Dr Mian Bi founded Medical Angels in Sydney in 2017, bridging a gap between a community of doctors seeking non-traditional investments and health-tech founders starved of seed capital. The syndicate formalises the clinical investing thesis that practitioners themselves are best positioned to evaluate medical innovations. Membership exceeds 1,000 medical and dental professionals across Australia, with an extended clinician network reaching 40,000. Medical Angels concentrates on early-stage health and medical technology companies, deploying member capital through its angel syndicate and a newly closed $40M Early Stage Venture Capital Limited Partnership fund announced in 2026 (per the firm). The syndicate's portfolio spans telehealth platforms, obstetric monitoring solutions, healthcare talent marketplaces, and VR technology. The 2026 fund continues an early-stage mandate — the group explicitly describes its role as filling the gap between friends-and-family rounds and larger VC funds that typically write cheques above $1 million. As of 2026 the firm operates from Sydney with no disclosed team headcount beyond its two physician co-founders. The launch of Medical Angels Venture Fund I marks a structural shift from pure syndicate to institutional fund manager, retaining the clinician-investor backbone that defines its sourcing edge (per the firm, 2026). Portfolio companies gain access to the network's clinical validation and distribution channels, which Hansra frames as a dual return: commercial upside plus measurable patient impact. Medical Angels' architecture fuses an angel syndicate of practising clinicians with a formal venture fund — a structure that embeds clinical due diligence and post-investment adoption support directly within the LP base. That clinician-sourcing-and-signalling flywheel is unusual among Australian health-tech investors, where domain-expert capital has historically been thin.
General information
Firm type
Venture Capital
Year founded
2017
AUM
Undisclosed
Location
Region
Oceania
Country
Australia
City
Sydney
Corporate office
Sydney, NSW, Australia
Principals
Amandeep Hansra
Co-Founder
Mian Bi
Co-Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Medical Angels?
Co-founders Dr Amandeep Hansra and Dr Mian Bi built the syndicate and set its investment strategy, according to the firm's own origin account. The group draws on its base of more than 1,000 clinical practitioners to surface and diligence health-tech opportunities, though the specific internal investment-committee structure has not been publicly disclosed. Hansra titles himself as Co-Founder and the public face of the firm's mission.
How does Medical Angels source its deal flow?
The syndicate's sourcing rests on a network of over 1,000 clinician members and an extended group of 40,000 medical contacts, giving it visibility into innovations that practising doctors encounter. Co-founder Amandeep Hansra describes the origin as connecting doctors with capital to health-tech founders who lacked seed funding. Portfolio companies also gain access to clinical validation and distribution through this network.
Is Medical Angels a single family office or a venture firm?
Medical Angels operates as an angel investment syndicate layered with a new venture capital arm. It started in 2017 as a member-based syndicate of Australian clinicians and launched its first dedicated fund in 2026 — Medical Angels Venture Fund I, a $40M ESVCLP. The firm is not a family office; it functions as a thematic asset manager drawing capital from a broad clinician membership.
What investment stages does Medical Angels target?
The group focuses on early-stage health-tech companies, explicitly positioning itself between the friends-and-family round and larger venture capital funds that write cheques above $1 million. Its 2026 fund carries an early-stage mandate consistent with the syndicate's historical deal size. The firm has backed companies in telehealth, obstetrics, healthcare marketplaces, and VR.
Which sectors does Medical Angels explicitly avoid?
The firm has not published a list of excluded sectors. Its entire disclosed portfolio and public commentary centre on health and medical technology. No non-health technology investments appear in available sources.
Does Medical Angels co-invest alongside external GPs?
Medical Angels describes its role as bridging the gap between seed-stage founders and later-stage VC funds, which suggests syndicate rounds typically precede or run parallel to institutional capital. The firm has not publicly disclosed specific co-investment partnerships or GP relationships.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: